Wolverine Asset Management’s Edwards Lifesciences EW Stock Holding History

Wolverine Asset Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,345	Closed	-$112K	–	2229
2021 Q1	$112K	Buy	1,345 +283	+27%	+$23.9K	﹤0.01%	1409
2020 Q4	$96K	Sell	1,062 -670	-39%	-$55.6K	﹤0.01%	1233
2020 Q3	$138K	Buy	1,732 +1,704	+6,086%	+$133K	﹤0.01%	1066
2020 Q2	$1K	Buy	+28	New	+$1.99K	﹤0.01%	1490
2014 Q1	–	Sell	-6,000	Closed	-$69.2K	–	2540
2013 Q4	$65K	Buy	6,000 +3,600	+150%	+$40.6K	﹤0.01%	1671
2013 Q3	$27K	Hold	2,400	–	–	﹤0.01%	1930
2013 Q2	$26K	Buy	+2,400	New	+$28.4K	﹤0.01%	1923

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Wolverine Asset Management's EW Position: Q2 2021 in Review

Wolverine Asset Management sold out of Edwards Lifesciences (EW) in Q2 2021, closing a stake of 1,345 shares — an estimated $112K sold.

Wolverine Asset Management first reported a position in EW in Q2 2013 and held it in 7 quarters. The position peaked at $138K in Q3 2020. 1,188 funds tracked by Wall St. Rank hold EW as of Q2 2021.

Wolverine Asset Management reported no remaining Edwards Lifesciences position as of Q2 2021 after selling out during the quarter.
Wolverine Asset Management sold 1,345 Edwards Lifesciences shares in Q2 2021, an estimated $112K.
Wolverine Asset Management first reported a position in Edwards Lifesciences in Q2 2013 and held it in 7 quarters.
Wolverine Asset Management's Edwards Lifesciences position peaked at $138K in Q3 2020.
1,188 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2021.

Based on Wolverine Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.